PDF herunterladen
Kardiologie up2date 2006; 2(3): 255-269
DOI: 10.1055/s-2006-944799
Koronare Herzerkrankung und Arteriosklerose
© Georg Thieme Verlag Stuttgart · New York

Schlagen Frauenherzen anders?

Geschlechtsunterschiede in Manifestation, Diagnostik und Therapie der koronaren HerzerkrankungVera  Regitz-Zagrosek, Christine  Espinola-Klein
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
05. Oktober 2006 (online)

Auch verfügbar auf
    Lizenzen und Reprints Alle Artikel dieser Rubrik

Einleitung

Die Manifestationen der koronaren Herzerkrankung (KHK) unterscheiden sich sehr deutlich zwischen Frauen und Männern, ebenso wie das Ergebnis therapeutischer Interventionen [1]. Es ist wichtig, dass die behandelnden Ärzte diese Unterschiede, die sicher in Zukunft an Bedeutung gewinnen werden, kennen. In dieser Übersichtsarbeit sind prägnante Geschlechterunterschiede in Epidemiologie und Klinik der KHK, in der zugrunde liegenden molekularen Pathophysiologie, Risikofaktoren und Diagnostik sowie in der medikamentösen Therapie zusammengefasst.

Literatur

  • 1 Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease.  Nat Rev Drug Discov. 2006;  5 425-439
    CrossrefPubMedGoogle Scholar
  • 2 Lowel H, Meisinger C, Heier M, Hormann A, Kuch B, Gostomzyk J, Koenig W. Sex specific trends of sudden cardiac death and acute myocardial infarction: results of the population-based KORA/MONICA-Augsburg register 1985 to 1998.  Dtsch Med Wochenschr. 2002;  127 2311-2316
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 3 Regitz-Zagrosek V, Lehmkuhl E, Lehmkuhl H B, Hetzer R. Gender aspects in heart failure. Pathophysiology and medical therapy.  Arch Mal Coeur Vaiss. 2004;  97 899-908
    PubMedGoogle Scholar
  • 4 Mieres J H, Shaw L J, Arai A. et al . Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association.  Circulation. 2005;  111 682-696
    CrossrefPubMedGoogle Scholar
  • 5 Redberg R F, Cannon R O 3rd, Bairey M erz, Lerman A, Reis S E, Sheps D S. Women’s Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2 - 4, 2002: Section 2: stable ischemia: pathophysiology and gender differences.  Circulation. 2004;  109 e47-49
    CrossrefPubMedGoogle Scholar
  • 6 Vaccarino V, Parsons L, Every N R, Barron H V, Krumholz H M. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants.  N Engl J Med. 1999;  341 217-225
    CrossrefPubMedGoogle Scholar
  • 7 Antoniucci D, Valenti R, Moschi G. et al . Sex-based differences in clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction.  Am J Cardiol. 2001;  87 289-293
    CrossrefPubMedGoogle Scholar
  • 8 Vaccarino V, Abramson J L, Veledar E, Weintraub W S. Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women.  Circulation. 2002;  105 1176-1181
    CrossrefPubMedGoogle Scholar
  • 9 Regitz-Zagrosek V, Lehmkuhl E, Hocher B. et al . Gender as a risk factor in young, not in old, women undergoing coronary artery bypass grafting.  J Am Coll Cardiol.. 2004;  44 2413-2414
    CrossrefPubMedGoogle Scholar
  • 10 Makkar R R, Fromm B S, Steinman R T, Meissner M D, Lehmann M H. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.  JAMA. 1993;  270 2590-2597
    CrossrefPubMedGoogle Scholar
  • 11 Rodriguez I, Kilborn M J, Liu X K, Pezzullo J C, Woosley R L. Drug-induced QT prolongation in women during the menstrual cycle.  JAMA. 2001;  285 1322-1326
    CrossrefPubMedGoogle Scholar
  • 12 Theres H, Maier B, Matteucci G othe. et al . Influence of gender on treatment and short-term mortality of patients with acute myocardial infarction in Berlin.  Z Kardiol. 2004;  93 954-963
    PubMedGoogle Scholar
  • 13 Yusuf S, Ounpuu S, Dans T, INTERHEART S tudy. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.  Lancet. 2004;  364 937-952
    CrossrefPubMedGoogle Scholar
  • 14 Shaw L J, Merz N B, Pepine C J. et al . for the WISE Investigation. Gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.  J Am Coll Cardiol. 2006;  46 4S-20S
    PubMedGoogle Scholar
  • 15 Stramba-Badiale M, Fox K M, Priori S G. et al . Cardiovascular diseases in women: a statement from the policy conference of the European society of cardiology.  Eur Heart J. 2006;  27 994-1005
    PubMedGoogle Scholar
  • 16 Tanis B C, van den Bosch M AAJ, Kemmeren J M. et al . Oral contraceptives and the risk of myocardial infarction.  N Engl J Med. 2001;  345 1787-1793
    CrossrefPubMedGoogle Scholar
  • 17 Diverse P opulations. Smoking, body weight, CHD mortality in diverse populations.  Prev Medicine. 2004;  38 834-840
    PubMedGoogle Scholar
  • 18 McLarty A, Mann N, Lawson W, Forster A. Womens heart health series: a mini-symposium.  Med Sci Monit. 2003;  9 103-110
    PubMedGoogle Scholar
  • 19 Fröhlicher E S, Miller N H, Christopherson D J. et al . High rates of sustained smoking cessation in women hospitalized with cardiovascular disease.  Circulation. 2004;  109 587-593
    CrossrefPubMedGoogle Scholar
  • 20 Manolio T A, Pearson T A, Wenger N K, Barrett-Connor E, Payne G H, Harlan W R. Cholesterop and heart disease in older persons and women. Review of an NHLBI workshop.  Ann Epidemiol. 1992;  2 161-176
    CrossrefPubMedGoogle Scholar
  • 21 Hokanson J E, Austin M A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein level: a meta-analysis of population based prospective Studies.  J Cardiovasc Risk. 1996;  3 213-219
    CrossrefPubMedGoogle Scholar
  • 22 Stessen J A, Ginocchio G, Thijs L, Fagard R. Conventional and ambulatori blood pressure and menopause in a prospective population study.  J Hum Hypertens. 1997;  11 507-514
    CrossrefPubMedGoogle Scholar
  • 23 Mason P J, Manson J E, Sesso H D. et al . Blood pressure and risk of secondary cardiovascular events in women.  Circulation. 2004;  109 1623-1629
    CrossrefPubMedGoogle Scholar
  • 24 Steingart R M, Packer M, Hamm P. et al . Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators.  N Engl J Med. 1991;  325 226-230
    CrossrefPubMedGoogle Scholar
  • 25 Conroy R M, Pyörälä K, Fitzgerald A P. et al . on behalf of the SCORE project group. Estimation of ten-year risk of fatatl cardiovascular disease in Europe: the SCORE project.  Eur Heart J. 2003;  24 987-1003
    CrossrefPubMedGoogle Scholar
  • 26 Huxley R, Barzi F, Woodward M. Excess of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.  BMJ. 2006;  332 73-78
    CrossrefPubMedGoogle Scholar
  • 27 Weiss R, Dziura J, Burgert T S. et al . Obesity and the metabolic syndrome in Children and Adolescents.  N Engl J Med. 2004;  350 2362-2374
    CrossrefPubMedGoogle Scholar
  • 28 Regitz-Zagrozek V, Lehmkuhl E, Weickert M O. Gender differences in the metabolic syndrome and their role for cardiovascualr disease.  Clin Res Cardiol. 2006;  95 136-147
    CrossrefPubMedGoogle Scholar
  • 29 Wessel T R, Arant C B, Olson M B. et al . Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.  JAMA. 2004;  292 1179-1187
    CrossrefPubMedGoogle Scholar
  • 30 Yusuf S, Hawken S, Ounpuu S. et al . ; INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27. 000 participants from 52 countries: a case-control study.  Lancet. 2005;  366 1640-1649
    CrossrefPubMedGoogle Scholar
  • 31 Li T Y, Rana J S, Manson J E. et al . Obesity as compared with physical activity in predicting risk of coronary artery disease.  Circulation. 2006;  113 499-506
    CrossrefPubMedGoogle Scholar
  • 32 Ross R. Atherosclerosis an inflammatory disease.  N Engl J Med. 1999;  340 115-126
    CrossrefPubMedGoogle Scholar
  • 33 Brezinka V, Kittel F. Psychosocial factors of coronary heart disease in women: a review.  Social Science and Medicine. 1996;  42 1351-1362
    CrossrefPubMedGoogle Scholar
  • 34 Bjerkest O, Nordahl H N, Mykletun A, Holmen J, Dahl A A. Anxiety and depression following myocardial infarction: gender differences in a 5-year prospective study.  J Psychosom Res. 2005;  58 153-161
    CrossrefPubMedGoogle Scholar
  • 35 Abogast A, Sechtem U. Diagnose der koronaren Herzkrankheit bei Frauen.  Dtsch Med Wochenschr. 2003;  128 97-102
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 36 Gibbons R J, Balady G J, Bricker J T. et al . ACC/AHA 2002 guidelines update for exercise testing: summary article: A report of the American College of Cardiology/American Heart Association task force on practice guidelines.  Circulation. 2002;  106 1883-1892
    CrossrefPubMedGoogle Scholar
  • 37 Mora S, Redberg R F, Cui Y. et al . Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study.  JAMA. 2003;  290 1600-1607
    CrossrefPubMedGoogle Scholar
  • 38 Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women.  Am J Cardiol. 1999;  83 660-666
    CrossrefPubMedGoogle Scholar
  • 39 Okin P M. Elektrocardiography in women. Taking the initiative.  Circulation. 2006;  113 464-466
    CrossrefPubMedGoogle Scholar
  • 40 Shaw L J, Vasey C, Sawada S, Rimmerman C, Marwick T H. Impact of gender on risk stratifitcation by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men.  Eur Heart J. 2005;  26 447-456
    PubMedGoogle Scholar
  • 41 Mieres J H, Shaw L J, Hendel R C. et al . ; Writing Group on Perfusion Imaging in Women. American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease-the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women.  J Nucl Cardiol. 2003;  10 95-101
    CrossrefPubMedGoogle Scholar
  • 42 Buchthal S D, den H ollander, Merz C NB. et al . Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms.  N Engl J Med. 2000;  342 829-835
    CrossrefPubMedGoogle Scholar
  • 43 Liao Y, Cooper R S, Mensah G A, McGee D L. Left ventricular hypertrophy has a greater impact on survival in women than in men.  Circulation. 1995;  92 805-810
    PubMedGoogle Scholar
  • 44 Cleland J G, Swedberg K, Follath F. et al . The EuroHeart Failure survey programme- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.  Eur Heart J. 2003;  24 442-463
    PubMedGoogle Scholar
  • 45 Mendelsohn M E, Karas R H. Molecular and cellular basis of cardiovascular gender differences.  Science. 2005;  308 1583-1587
    CrossrefPubMedGoogle Scholar
  • 46 Nordmeyer J, Eder S, Mahmoodzadeh S. et al . Upregulation of myocardial estrogen receptors in human aortic stenosis.  Circulation. 2004;  110 3270-3275
    CrossrefPubMedGoogle Scholar
  • 47 Mahmoodzadeh S, Eder S, Nordmeyer J. et al . Estrogen receptor alpha up-regulation and redistribution in human heart failure.  Faseb J. 2006;  20 926-934
    CrossrefPubMedGoogle Scholar
  • 48 Edwards D P. Regulation of signal transduction pathways by estrogen and progesterone.  Annu Rev Physiol. 2005;  67 335-376
    CrossrefPubMedGoogle Scholar
  • 49 Dubey R K, Tofovic S P, Jackson E K. Cardiovascular pharmacology of estradiol metabolites.  J Pharmacol Exp Ther. 2004;  308 403-409
    PubMedGoogle Scholar
  • 50 Sudhir K, Komesaroff P A. Clinical review 110: Cardiovascular actions of estrogens in men.  J Clin Endocrinol Metab. 1999;  84 3411-3415
    CrossrefPubMedGoogle Scholar
  • 51 Herrington D M, Howard T D. ER-alpha variants and the cardiovascular effects of hormone replacement therapy.  Pharmacogenomics. 2003;  4 269-277
    CrossrefPubMedGoogle Scholar
  • 52 Berry C, Kelly J, Cobbe S M, Eteiba H. Comparison of femoral bleeding complication after coronary angiography versus percutaneous coronary intervention.  Am J Cardiol. 2004;  94 361-363
    CrossrefPubMedGoogle Scholar
  • 53 Rubanyi G M, Kauser K, Johns A. Role of estrogen receptors in the vascular system.  Vascul Pharmacol. 2002;  38 81-88
    CrossrefPubMedGoogle Scholar
  • 54 Rathore S S, Wang Y, Krumholz H M. Sex-based differences in the effect of digoxin for the treatment of heart failure.  N Engl J Med. 2002;  347 1403-1411
    CrossrefPubMedGoogle Scholar
  • 55 Rathore S S, Curtis J P, Wang Y, Bristow M R, Krumholz H M. Association of serum digoxin concentration and outcomes in patients with heart failure.  JAMA. 2003;  289 871-878
    CrossrefPubMedGoogle Scholar
  • 56 Luzier A B, Killian A, Wilton J H, Wilson M F, Forrest A, Kazierad D J. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.  Clin Pharmacol Ther. 1999;  66 594-601
    PubMedGoogle Scholar
  • 57 TheMERIT-HFStudyGroup . Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).  Lancet. 1999;  353 2001-2007
    CrossrefPubMedGoogle Scholar
  • 58 Packer M, Bristow M R, Cohn J N, Colucci W S, Fowler M B, Gilbert E M, Shusterman N H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U. S. Carvedilol Heart Failure Study Group.  N Engl J Med. 1996;  334 1349-1355
    CrossrefPubMedGoogle Scholar
  • 59 Simon T, Mary-Krause M, Funck-Brentano C, Jaillon P. Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II).  Circulation. 2001;  103 375-380
    PubMedGoogle Scholar
  • 60 CIBISII1999 . The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.  Lancet. 1999;  353 9-13
    CrossrefPubMedGoogle Scholar
  • 61 Wing L M, Reid C M, Ryan P. et al . A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly.  N Engl J Med. 2003;  348 583-592
    CrossrefPubMedGoogle Scholar
  • 62 Mackay F J, Pearce G L, Mann R D. Cough and angiotensin II receptor antagonists: cause or confounding?.  Br J Clin Pharmacol. 1999;  47 111-114
    CrossrefPubMedGoogle Scholar
  • 63 Ridker P M, Cook N R, Lee I M. et al . A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.  N Engl J Med. 2005;  352 1293-1304
    CrossrefPubMedGoogle Scholar
  • 64 Martin R M, Biswas P N, Freemantle S N, Pearce G L, Mann R D. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies.  Br J Clin Pharmacol. 1998;  46 505-511
    CrossrefPubMedGoogle Scholar
  • 65 Solomon C G, Hu F B, Dunaif A. et al . Menstrual cycle irregularity and risk for future cardiovascular disease.  J Clin Endocrinol Metab. 2002;  87 2013-2017
    CrossrefPubMedGoogle Scholar

Prof. Dr. Vera Regitz-Zagrosek

Center for Gender in Medicine and Cardiovascular Research Center, Charité and Deutsches Herzzentrum Berlin (DHZB)

Augustenburger Platz 1
13353 Berlin

eMail: vera.regitz-zagrosek@charite.de

      >